Phase 3 study of TAF-containing combination STR in HIV-1 subjects

• Research type

  Research Study

• Full title

  A Phase 3, Open-Label Study to Evaluate Switching from a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically Suppressed, HIV1 Positive Subjects

• IRAS ID

  124704

• Contact name

  Graeme Moyle

• Contact email

  Graeme.Moyle@chelwest.nhs.uk

• Sponsor organisation

  Gilead Sciences, Inc.

• Eudract number

  2012-005114-20

• Clinicaltrials.gov Identifier

  NCT01815736

• REC name

  South Central - Hampshire B Research Ethics Committee

• REC reference

  13/SC/0279

• Date of REC Opinion

  10 Jul 2013

• REC opinion

  Further Information Favourable Opinion